Clinical Trial Update: SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

Phase 2 trial update for SHR-2004 evaluating prevention of venous thromboembolism in patients undergoing total knee arthroplasty; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• SHR-2004

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Prevention of Venous Thromboembolism After Knee Arthroplasty | Phase 2 | Status: COMPLETED